Cargando…
Clinical implications of interleukins-31, 32, and 33 in gastric cancer
BACKGROUND: Gastric cancer (GC) is one of the most common malignancies in China with a high morbidity and mortality. AIM: To determine whether interleukin (IL)-31, IL-32, and IL-33 can be used as biomarkers for the detection of GC, via evaluating the correlations between their expression and clinico...
Autores principales: | Liu, Qing-Hua, Zhang, Ji-Wei, Xia, Lei, Wise, Steven G, Hambly, Brett David, Tao, Kun, Bao, Shi-San |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516641/ https://www.ncbi.nlm.nih.gov/pubmed/36187404 http://dx.doi.org/10.4251/wjgo.v14.i9.1808 |
Ejemplares similares
-
Expression of interleukin-32 in bone marrow of patients with myeloma and its prognostic significance
por: Wang, Gang, et al.
Publicado: (2019) -
Mining The Cancer Genome Atlas database for tumor mutation burden and its clinical implications in gastric cancer
por: Zhao, Dong-Yan, et al.
Publicado: (2021) -
Inverse correlation between Interleukin-34 and gastric cancer, a potential biomarker for prognosis
por: Liu, Qinghua, et al.
Publicado: (2020) -
Effect of T-regulatory cells and interleukin-35, interleukin-10, and transforming growth factor-beta on diffuse large B-cell lymphoma
por: Wu, Hao, et al.
Publicado: (2023) -
Construction and analysis of an ulcer risk prediction model after endoscopic submucosal dissection for early gastric cancer
por: Gong, San-Dong, et al.
Publicado: (2022)